Ritonavir Completed Phase 1 Trials for Human Immunodeficiency Virus (HIV) Infections Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care1
clinicaltrials.gov IdentifierTitleDrugs
NCT02034838Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study